Here are some of the ways we may be able to help:

Insurance Navigation Icon

Insurance Navigation

  • Insurance coverage benefits verification
  • Prior authorization and appeal support as needed
  • Medication delivery to home or preferred address
Access Solutions Icon

Access Solutions

  • Copay assistance for eligible commercially insured individuals whose health plan covers DUVYZAT
    - Eligible patients may pay as little as $0
  • Education about third-party resources
  • Patient assistance program for eligible uninsured and underinsured patients
  • Temporary supply programs to help ensure timely start and treatment adherence
Education and Adherence Icon

Education and Adherence

  • Personalized pharmacist support
  • Disease and therapy educational materials
  • Coordination with families and healthcare providers, including refill reminders
  • Translation services available as needed

Each patient’s eligibility for access programs is evaluated on an individual basis. To be eligible, patients must meet the FDA-approved indication. All programs may be modified or discontinued at any time based on eligibility, state and federal laws, and program availability.

Restrictions apply. See full restrictions for ARC Copay Program, Patient Assistance Program, and temporary supply programs here.

Prescribe DUVYZAT and enroll your patients in ITF ARC

ITF ARC is committed to providing personalized support to help make starting and staying on therapy as prescribed as simple as possible.

ARC Patient Start Form Icon

Prescribe DUVYZAT and enroll individuals taking DUVYZAT in ITF ARC today—download the Patient Start Form below, fill it out, and submit it.

Download Patient Start Form

English en Español

Have questions? Contact us.

1-855-4 ITF ARC (1-855-448-3272)
8 AM-8 PM ET, Monday-Friday

Patient Resources

Resources FAQs Icon

FAQs

Answers to common questions that patients might have about DUVYZAT.

English en Español
Resources Patient Start Form Icon

ITF ARC
Patient Services Brochure

A quick reference guide for how ITF ARC can help patients.

English en Español

Indication and Important Safety Information

What is DUVYZAT?

DUVYZAT is a prescription medicine that is used for the treatment of Duchenne muscular dystrophy (DMD) in people 6 years of age and older.

Indication and Important Safety Information

What is DUVYZAT?

DUVYZAT is a prescription medicine that is used for the treatment of Duchenne muscular dystrophy (DMD) in people 6 years of age and older.

It is not known if DUVYZAT is safe and effective in children under 6 years of age.

Important Safety Information

What is the most important information I should know about DUVYZAT?

  • Low platelet counts in your blood (thrombocytopenia). Platelets are important for blood clotting, and a decrease in their numbers can lead to an increased risk of bleeding or bruising. Your healthcare provider will check your blood count before you start DUVYZAT and regularly during treatment for any signs of thrombocytopenia. Call your healthcare provider right away if you notice any unusual bleeding or small red or purple spots on the skin called petechiae. Your healthcare provider may change your dose of DUVYZAT if your blood platelet counts continue to be low or may stop your treatment with DUVYZAT.
  • Increased levels of fat (triglycerides) in your blood. You may not have any symptoms, so your healthcare provider will do blood tests before you start DUVYZAT and regularly during treatment to check your triglyceride levels. Your healthcare provider may change your dose of DUVYZAT if your triglyceride levels continue to be high or may stop your treatment with DUVYZAT.
  • Frequent watery loose stools (diarrhea) and vomiting. DUVYZAT can cause vomiting and moderate to severe diarrhea. If diarrhea occurs, you should keep track of the frequency and severity of your diarrhea symptoms, drink plenty of fluids, and contact your healthcare provider. Your healthcare provider may change your dose of DUVYZAT if the diarrhea cannot be managed or does not go away. Your healthcare provider may also stop your treatment with DUVYZAT.

Before taking DUVYZAT, tell your healthcare provider about all of your medical conditions, including if you:

  • have any heart problems or if you take any medicines that could increase your chance for irregular heart rhythms.
  • have any bleeding problems.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Taking DUVYZAT with certain other medicines may affect each other. Taking DUVYZAT with other medicines can cause serious side effects. Do not start or stop other medicines without talking to your healthcare provider.

DUVYZAT can cause serious side effects, including:

  • See “What is the most important information I should know about DUVYZAT?”
  • Changes in the electrical activity of your heart called QT Prolongation. QT Prolongation can increase the risk of developing a type of irregular heart rhythm known as Torsades de Pointes. Call your healthcare provider right away if you feel faint, have an irregular heartbeat, feel dizzy, or lose consciousness.

The most common side effects of DUVYZAT included diarrhea, nausea, vomiting, stomach pain, low platelet counts in the blood, increased fat level in the blood, and fever.

These are not all of the possible side effects of DUVYZAT. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see full Prescribing Information and Medication Guide.